These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 33903672

  • 1. A novel cystathionine γ-lyase inhibitor, I194496, inhibits the growth and metastasis of human TNBC via downregulating multiple signaling pathways.
    Liu Y, Wang L, Zhang X, Deng Y, Pan L, Li H, Shi X, Wang T.
    Sci Rep; 2021 Apr 26; 11(1):8963. PubMed ID: 33903672
    [Abstract] [Full Text] [Related]

  • 2. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Wang L, Shi H, Liu Y, Zhang W, Duan X, Li M, Shi X, Wang T.
    Int J Oncol; 2019 Aug 26; 55(2):473-487. PubMed ID: 31173185
    [Abstract] [Full Text] [Related]

  • 3. Cystathionine-γ-lyase contributes to tamoxifen resistance, and the compound I194496 alleviates this effect by inhibiting the PPARγ/ACSL1/STAT3 signalling pathway in oestrogen receptor-positive breast cancer.
    Fu H, Han X, Guo W, Zhao X, Yu C, Zhao W, Feng S, Wang J, Zhang Z, Lei K, Li M, Wang T.
    Sci Rep; 2024 Oct 03; 14(1):22988. PubMed ID: 39362925
    [Abstract] [Full Text] [Related]

  • 4. I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.
    Wang L, Shi H, Zhang X, Zhang X, Liu Y, Kang W, Shi X, Wang T.
    Oncol Rep; 2019 Jan 03; 41(1):427-436. PubMed ID: 30365149
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet drug ticagrelor suppresses triple negative breast cancer metastasis by targeting PI3K.
    Wang R, Jia S, Chen H, Luo K, Zhang L, Song Y, Qing C, Liu D, Zhou H.
    Biochem Pharmacol; 2024 Aug 03; 226():116408. PubMed ID: 38969297
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis.
    Gautam J, Banskota S, Lee H, Lee YJ, Jeon YH, Kim JA, Jeong BS.
    Exp Mol Med; 2018 Sep 05; 50(9):1-14. PubMed ID: 30185799
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological Inhibition of Endogenous Hydrogen Sulfide Attenuates Breast Cancer Progression.
    Khan NH, Wang D, Wang W, Shahid M, Khattak S, Ngowi EE, Sarfraz M, Ji XY, Zhang CY, Wu DD.
    Molecules; 2022 Jun 23; 27(13):. PubMed ID: 35807290
    [Abstract] [Full Text] [Related]

  • 9. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
    Song X, Zhou X, Qin Y, Yang J, Wang Y, Sun Z, Yu K, Zhang S, Liu S.
    Int J Mol Med; 2018 Jul 23; 42(1):579-588. PubMed ID: 29693154
    [Abstract] [Full Text] [Related]

  • 10. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
    Kim S, Lee J, Jeon M, Lee JE, Nam SJ.
    Oncotarget; 2016 Jan 12; 7(2):1544-58. PubMed ID: 26637807
    [Abstract] [Full Text] [Related]

  • 11. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
    Tian J, Chen X, Fu S, Zhang R, Pan L, Cao Y, Wu X, Xiao H, Lin HJ, Lo HW, Zhang Y, Lin J.
    Breast Cancer Res Treat; 2019 Jun 12; 175(3):553-566. PubMed ID: 30852762
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
    Zhu Z, Wang H, Qian X, Xue M, Sun A, Yin Y, Tang J, Zhang J.
    Clin Breast Cancer; 2024 Jun 12; 24(4):e244-e257.e1. PubMed ID: 38378361
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Wnt/β-catenin signaling induces the transcription of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
    Fan K, Li N, Qi J, Yin P, Zhao C, Wang L, Li Z, Zha X.
    Cell Signal; 2014 Dec 12; 26(12):2801-8. PubMed ID: 25193114
    [Abstract] [Full Text] [Related]

  • 17. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N, Bayraktar R, Kahraman N, Mokhlis HA, Calin GA, Lopez-Berestein G, Ozpolat B.
    Breast Cancer Res Treat; 2018 Oct 12; 171(3):593-605. PubMed ID: 29971628
    [Abstract] [Full Text] [Related]

  • 18. C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
    Cho TM, Kim JY, Kim YJ, Sung D, Oh E, Jang S, Farrand L, Hoang VH, Nguyen CT, Ann J, Lee J, Seo JH.
    Cancer Lett; 2019 Apr 10; 447():141-153. PubMed ID: 30703411
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.
    Shen Y, Zhang W, Liu J, He J, Cao R, Chen X, Peng X, Xu H, Zhao Q, Zhong J, Ding W, Lei X, Jiang Y, Zu X.
    Int J Cancer; 2019 Feb 01; 144(3):651-664. PubMed ID: 30289981
    [Abstract] [Full Text] [Related]

  • 20. Role of the cystathionine γ lyase/hydrogen sulfide pathway in human melanoma progression.
    Panza E, De Cicco P, Armogida C, Scognamiglio G, Gigantino V, Botti G, Germano D, Napolitano M, Papapetropoulos A, Bucci M, Cirino G, Ianaro A.
    Pigment Cell Melanoma Res; 2015 Jan 01; 28(1):61-72. PubMed ID: 25205294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.